Page last updated: 2024-09-04

atractylenolide iii and Colonic Neoplasms

atractylenolide iii has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, S; Chen, S; Li, X; Liu, M; Song, D; Zhang, D; Zhang, Z	1

Other Studies

1 other study(ies) available for atractylenolide iii and Colonic Neoplasms

Article	Year
Atractylenolide III induces apoptosis by regulating the Bax/Bcl-2 signaling pathway in human colorectal cancer HCT-116 Cells in vitro and in vivo. Anti-cancer drugs, 2022, 01-01, Volume: 33, Issue:1 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Lactones; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-bcl-2; Rats; Sesquiterpenes; Signal Transduction; Xenograft Model Antitumor Assays	2022

Article

Year

Atractylenolide III induces apoptosis by regulating the Bax/Bcl-2 signaling pathway in human colorectal cancer HCT-116 Cells in vitro and in vivo.

Anti-cancer drugs, 2022, 01-01, Volume: 33, Issue:1

Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Lactones; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-bcl-2; Rats; Sesquiterpenes; Signal Transduction; Xenograft Model Antitumor Assays

2022